[1] 陈煜, 李爽. 人工肝支持系统的临床应用. 临床荟萃, 2016, 31:717-722. [2] 金华. DPMAS模式人工肝治疗早期乙肝相关慢加急性肝衰竭的有效性分析. 当代医学, 2020, 26:46-48. [3] Yao J, Li S, Zhou L, et al. Therapeutic effect of double plasma molecular adsorption system and sequential half-dose plasma exchange in patients with HBV-related acute-on-chronic liver failure. J Clin Apher, 2019, 34:392-398. [4] Guo X, Wu F, Guo W, et al. Comparison of plasma exchange, double plasma molecular adsorption system, and their combination in treating acute-on-chronic liver failure. J Int Med Res, 2020, 48:1220731605. [5] 张秀灵, 段志文, 杨瑞东, 等. 血源紧张条件下血浆置换联合双重血浆分子吸附系统治疗早中期肝衰竭患者临床研究. 实用肝脏病杂志, 2019, 22:289-290. [6] 张茜, 蔡辛. 双重胆红素吸附系统治疗高胆红素血症的疗效观察. 贵州医药, 2019, 43:1389-1390. [7] 许开亮, 雷鸣, 袁维方, 等. 双重血浆分子吸附系统治疗肝衰竭高胆红素患者疗效研究. 创伤与急危重病医学, 2020, 8:91-93, 96. [8] 袁素娥, 周阳, 谭德明, 等. 肝素在分子吸附再循环治疗肝衰竭中的应用及对凝血指标的影响. 中南大学学报(医学版), 2011:830-835. [9] 马元吉, 许艳, 白浪, 等. 肝素钠与枸橼酸钠封管液在人工肝治疗肝衰竭患者的应用比较. 实用肝脏病杂志, 2020, 23:66-69. [10] 张红玉, 崔慧斐. 肝素药理作用和药物制剂的研究新进展. 中国药学杂志, 2019, 54:1831-1839. [11] 翟原苑, 马海平, 郑宏, 等. 肝素与抗凝监测的研究进展. 临床和实验医学杂志, 2018, 17:111-113. [12] Lisman T, Caldwell SH, Burroughs AK, et al. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol, 2010, 53:362-371. [13] Kujovich JL. Coagulopathy in liver disease: a balancing act. Hematology Am Soc Hematol Educ Program, 2015, 2015:243-249. [14] O'Leary JG, Greenberg CS, Patton HM, et al. AGA clinical practice update: coagulation in cirrhosis. Gastroenterology, 2019, 157:34-43. [15] 武婷, 文其祥. 体外循环对内分泌系统的影响. 中国体外循环杂志, 2008, 6:122-125, 115. |